Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Inflammation ; 44(2): 769-779, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33180227

RESUMO

Accumulating studies show that microRNAs are candidate biomarkers and therapeutic targets for cardiovascular diseases including myocardial infarction (MI). Bioinformatics analysis suggested that compared with Sprague-Dawley (SD) rats without MI, miR-30e-5p expression in the left ventricle tissue of SD rats with MI was significantly downregulated, suggesting miR-30e-5p may participate in the pathogenesis of MI. In this study, H9c2 cardiomyocytes were exposed to hypoxia to establish a hypoxic cell model. SD rats with left anterior descending coronary artery ligation were used for the MI animal model. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to evaluate the miR-30e-5p and PTEN mRNA expressions in cells and tissues. Western blot was used for detecting the expression of PTEN protein. miR-30e-5p expression in H9c2 cells was then inhibited or overexpressed, and its effects on viability and apoptosis were examined by cell counting kit-8 (CCK-8) assay and TUNEL assay, respectively. ELISA was used to detect inflammatory factors. The regulatory relationship between PTEN and miR-30e-5p was investigated by bioinformatics analysis, qRT-PCR, Western blot, and dual-luciferase reporter assay. It was found that miR-30e-5p expression was significantly downregulated in animal models and H9c2 cells under hypoxia. Overexpression of miR-30e-5p led to a dramatic increase of cell viability, accompanied by the decrease of IL-1ß, TNF-α, IL-6, LDH, CK-MB, and cTnI. Furthermore, PTEN was identified as a target of miR-30e-5p, and PTEN overexpression reversed the effects of miR-30e -5p on H9c2 cells. To conclude, we confirm that miR-30e-5p alleviates inflammation and myocardial injury induced by MI via suppressing PTEN.


Assuntos
Inflamação/genética , MicroRNAs/metabolismo , Infarto do Miocárdio/genética , Miócitos Cardíacos/metabolismo , PTEN Fosfo-Hidrolase/metabolismo , Animais , Apoptose , Biomarcadores/metabolismo , Western Blotting , Linhagem Celular , Biologia Computacional , Regulação para Baixo , Ensaio de Imunoadsorção Enzimática , Regulação da Expressão Gênica , Hipóxia/metabolismo , Hipóxia/patologia , Hipóxia/fisiopatologia , Marcação In Situ das Extremidades Cortadas , Inflamação/metabolismo , Inflamação/patologia , Inflamação/fisiopatologia , Masculino , Infarto do Miocárdio/metabolismo , Infarto do Miocárdio/patologia , Infarto do Miocárdio/fisiopatologia , Miócitos Cardíacos/parasitologia , Miócitos Cardíacos/patologia , PTEN Fosfo-Hidrolase/genética , Ratos , Ratos Sprague-Dawley , Reação em Cadeia da Polimerase em Tempo Real
2.
Oxid Med Cell Longev ; 2020: 8867701, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33376582

RESUMO

Chagas disease is a neglected tropical disease, which affects an estimate of 6-7 million people worldwide. Chagas disease is caused by Trypanosoma cruzi, which is a eukaryotic flagellate unicellular organism. At the primary infection sites, these parasites are phagocytized by macrophages, which produce reactive oxygen species (ROS) in response to the infection with T. cruzi. The ROS produce damage to the host tissues; however, macrophage-produced ROS is also used as a signal for T. cruzi proliferation. At the later stages of infection, mitochondrial ROS is produced by the infected cardiomyocytes that contribute to the oxidative damage, which persists at the chronic stage of the disease. The oxidative damage leads to a functional impairment of the heart. In this review article, we will discuss the mechanisms by which T. cruzi is able to deal with the oxidative stress and how this helps the parasite growth at the acute phase of infection and how the oxidative stress affects the cardiomyopathy at the chronic stage of the Chagas disease. We will describe the mechanisms used by the parasite to deal with ROS and reactive nitrogen species (RNS) through the trypanothione and the mechanisms used to repair the damaged DNA. Also, a description of the events produced by ROS at the acute and chronic stages of the disease is presented. Lastly, we discuss the benefits of ROS for T. cruzi growth and proliferation and the possible mechanisms involved in this phenomenon. Hypothesis is put forward to explain the molecular mechanisms by which ROS triggers parasite growth and proliferation and how ROS is able to produce a long persisting damage on cardiomyocytes even in the absence of the parasite.


Assuntos
Doença de Chagas/metabolismo , Macrófagos/metabolismo , Miócitos Cardíacos/metabolismo , Espécies Reativas de Nitrogênio/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Trypanosoma cruzi/metabolismo , Animais , Doença de Chagas/patologia , Doença Crônica , Humanos , Macrófagos/parasitologia , Macrófagos/patologia , Miócitos Cardíacos/parasitologia , Miócitos Cardíacos/patologia , Oxirredução
3.
Methods Mol Biol ; 2116: 773-780, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32221954

RESUMO

The advances in development and popularization of automated fluorescence microscopes and pipetting robots allowed scientists to establish high-throughput compound screening using image-based assays for Trypanosoma cruzi intracellular forms, which are associated to chronic Chagas disease. An intracellular T. cruzi image-based assay is a valuable tool to early stage drug discovery for Chagas disease, because it allows scientists to assess a compound's efficacy and safety in the same experiment. During the last 10 years, several improvements have been incorporated into intracellular T. cruzi assay protocols to make them more predictable in what happens with parasites within an infected organism. In the present chapter, a protocol will be presented for an intracellular T. cruzi assay, but at a low-throughput scale, more compatible with facilities in many academic laboratories.


Assuntos
Doença de Chagas/tratamento farmacológico , Descoberta de Drogas/métodos , Processamento de Imagem Assistida por Computador , Tripanossomicidas/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Animais , Linhagem Celular , Doença de Chagas/parasitologia , Chlorocebus aethiops , Doença Crônica , Células Epiteliais/parasitologia , Humanos , Estágios do Ciclo de Vida/efeitos dos fármacos , Microscopia de Fluorescência/instrumentação , Microscopia de Fluorescência/métodos , Miócitos Cardíacos/parasitologia , Testes de Sensibilidade Parasitária/métodos , Ratos , Tripanossomicidas/uso terapêutico , Trypanosoma cruzi/fisiologia
4.
Poult Sci ; 98(3): 1134-1145, 2019 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-30329111

RESUMO

Fowl adenovirus serotype 4 (FAdV-4) is the causative agent of hydropericardium syndrome (HPS), which is characterized by the accumulation of a clear, straw-colored fluid in the pericardial sac, and high mortality rates. In order to explore the mechanism of FAdV-4-induced cardiac damage, dynamic pathology, apoptosis, and inflammatory reactions were analyzed in vivo. Moreover, we detected viral proliferation, and ultrastructure, inflammation and apoptosis of cardiomyocytes (CM) after FAdV-4 infection in vitro. The results showed that FAdV-4 impaired cardiac integrity and function by causing apoptosis and inflammation in vivo. Flow cytometry showed that CM infected with FAdV-4 did not show apoptosis in vitro. In addition, the mRNA expression of four inflammatory cytokines (interleukin (il)1B, il6, il8, and tumor necrosis factor), and activity of three myocardial enzymes were significantly different between FAdV-4 and control groups. However, in vitro, these indexes showed no significant difference between the groups. These observations collectively indicated that the heart was not the target organ of FAdV-4, and the virus may not directly lead to the occurrence of CM apoptosis and inflammation. To explore the source of pericardial effusion, we measured total protein, albumin, aspartate aminotransferase, creatine kinase isoenzyme, lactate dehydrogenase, potassium, sodium, and chloride ions in serum and pericardial effusion. Pericardial effusion was derived from vascular exudation rather than CM degeneration. Further studies are needed to investigate the exudation mechanism of vascular endothelial cells in FAdV-4 infection then weakened or eliminated pericardial effusion to minimize heart injury and/or restore damaged CM.


Assuntos
Infecções por Adenoviridae/veterinária , Apoptose/imunologia , Aviadenovirus/fisiologia , Galinhas , Derrame Pericárdico/veterinária , Doenças das Aves Domésticas/patologia , Infecções por Adenoviridae/imunologia , Infecções por Adenoviridae/patologia , Infecções por Adenoviridae/virologia , Animais , Miócitos Cardíacos/imunologia , Miócitos Cardíacos/parasitologia , Derrame Pericárdico/imunologia , Derrame Pericárdico/patologia , Derrame Pericárdico/virologia , Doenças das Aves Domésticas/imunologia , Doenças das Aves Domésticas/virologia , Distribuição Aleatória
5.
J Cell Biochem ; 120(3): 3373-3383, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30246366

RESUMO

The aim of this study was to evaluate the efficacy of vaccine using replication-deficient human recombinant Type 5 replication-defective adenoviruses (AdHu5) carrying sequences of the amastigote surface protein 2 (ASP2) (AdASP2) in mice infected with the Trypanosoma cruzi ( T cruzi) Y strain. A total of 16 A/Sn mice female were distributed into four groups, as follows (n = 4 per group): Group 1 - Control Group (CTRL); Group 2 - Infected Group (TC): animals were infected by subcutaneous route with 150 bloodstream trypomastigotes of T cruzi Y strain; Group 3 - Immunized Group (AdASP-2): animals were immunized by intramuscular injection (im) route with 50 µL of AdSP-2 (2 × 10 8 plaque forming units [pfu]/cam) at day 0; Group 4-Immunized and Infected Group (AdASP-2+TC): animals were immunized by im route with 50 µL of ASP-2 (2 × 10 8 pfu/cam) and infected by T cruzi at the same day (day 0). It was observed a significant decrease of nests in the group that was immunized with AdASP-2 and infected on the same day. Tumor necrosis factor alpha (TNF-α) and inducible nitric oxide synthase (iNOS) gene expressions showed a significant increase in the AdASP-2+TC group when compared to TC group, but it was noted that Cyclooxygenase-2 (Cox-2) was increased in TC group when compared to AdASP-2+TC group. Increase of matrix metalloproteinases-2 (MMP-2) and decrease of MMP-9 immunoexpression in the AdASP-2+TC group was noticed as well. Oxidative DNA damage was present in myocardium for AdASP-2+TC group as a result of 8-hydroxydeoxyguanosine immunoexpression. Taken together, our results highlighted an increased oxidative stress, MMP-2 activity and inflammatory host response promoted by AdASP-2 against T cruzi infection.


Assuntos
Doença de Chagas/prevenção & controle , Miócitos Cardíacos/imunologia , Estresse Oxidativo , Parasitemia/prevenção & controle , Vacinas Protozoárias/administração & dosagem , Trypanosoma cruzi/imunologia , Animais , Doença de Chagas/imunologia , Doença de Chagas/parasitologia , Feminino , Imunização , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Camundongos , Miócitos Cardíacos/parasitologia , Neuraminidase , Parasitemia/imunologia , Vacinas Protozoárias/imunologia , Vacinas Atenuadas/administração & dosagem , Vacinas Atenuadas/imunologia
6.
Mem. Inst. Oswaldo Cruz ; 114: e180593, 2019. graf
Artigo em Inglês | LILACS | ID: biblio-1020079

RESUMO

BACKGROUND Cardiac physiology depends on coupling and electrical and mechanical coordination through the intercalated disc. Focal adhesions offer mechanical support and signal transduction events during heart contraction-relaxation processes. Talin links integrins to the actin cytoskeleton and serves as a scaffold for the recruitment of other proteins, such as paxillin in focal adhesion formation and regulation. Chagasic cardiomyopathy is caused by infection by Trypanosoma cruzi and is a debilitating condition comprising extensive fibrosis, inflammation, cardiac hypertrophy and electrical alterations that culminate in heart failure. OBJECTIVES Since mechanotransduction coordinates heart function, we evaluated the underlying mechanism implicated in the mechanical changes, focusing especially in mechanosensitive proteins and related signalling pathways during infection of cardiac cells by T. cruzi. METHODS We investigated the effect of T. cruzi infection on the expression and distribution of talin/paxillin and associated proteins in mouse cardiomyocytes in vitro by western blotting, immunofluorescence and quantitative real-time polymerase chain reaction (qRT-PCR). FINDINGS Talin and paxillin spatial distribution in T. cruzi-infected cardiomyocytes in vitro were altered associated with a downregulation of these proteins and mRNAs levels at 72 h post-infection (hpi). Additionally, we observed an increase in the activation of the focal adhesion kinase (FAK) concomitant with increase in β-1-integrin at 24 hpi. Finally, we detected a decrease in the activation of FAK at 72 hpi in T. cruzi-infected cultures. MAIN CONCLUSION The results suggest that these changes may contribute to the mechanotransduction disturbance evidenced in chagasic cardiomyopathy.


Assuntos
Animais , Camundongos , Trypanosoma cruzi/fisiologia , Cardiomiopatia Chagásica/metabolismo , Miócitos Cardíacos/parasitologia , Mecanotransdução Celular/genética , Western Blotting , Reação em Cadeia da Polimerase , Imunofluorescência , Paxilina/metabolismo
7.
Biochem J ; 475(7): 1235-1251, 2018 04 05.
Artigo em Inglês | MEDLINE | ID: mdl-29438066

RESUMO

Chagas disease (CD), caused by the protozoa Trypanosoma cruzi, is a chronic illness in which parasites persist in the host-infected tissues for years. T. cruzi invasion in cardiomyocytes elicits the production of pro-inflammatory mediators [TNF-α, IL-1ß, IFN-γ; nitric oxide (·NO)], leading to mitochondrial dysfunction with increased superoxide radical (O2·-), hydrogen peroxide (H2O2) and peroxynitrite generation. We hypothesize that these redox mediators may control parasite proliferation through the induction of intracellular amastigote programmed cell death (PCD). In this work, we show that T. cruzi (CL-Brener strain) infection in primary cardiomyocytes produced an early (24 h post infection) mitochondrial dysfunction with H2O2 generation and the establishment of an oxidative stress evidenced by FoxO3 activation and target host mitochondrial protein expression (MnSOD and peroxiredoxin 3). TNF-α/IL-1ß-stimulated cardiomyocytes were able to control intracellular amastigote proliferation compared with unstimulated cardiomyocytes. In this condition leading to oxidant formation, an enhanced number of intracellular apoptotic amastigotes were detected. The ability of H2O2 to induce T. cruzi PCD was further confirmed in the epimastigote stage of the parasite. H2O2 treatment induced parasite mitochondrial dysfunction together with intra-mitochondrial O2·- generation. Importantly, parasites genetically engineered to overexpress mitochondrial Fe-superoxide dismutase (Fe-SODA) were more infective to TNF-α/IL-1ß-stimulated cardiomyocytes with less apoptotic amastigotes; this result underscores the role of this enzyme in parasite survival. Our results indicate that cardiomyocyte-derived diffusible mediators are able to control intracellular amastigote proliferation by triggering T. cruzi PCD and that parasite Fe-SODA tilts the process toward survival as part of an antioxidant-based immune evasion mechanism.


Assuntos
Doença de Chagas/parasitologia , Interações Hospedeiro-Parasita , Ferro/metabolismo , Mitocôndrias/patologia , Miócitos Cardíacos/patologia , Estresse Oxidativo , Superóxido Dismutase/metabolismo , Animais , Apoptose , Células Cultivadas , Doença de Chagas/metabolismo , Doença de Chagas/patologia , Camundongos , Camundongos Endogâmicos BALB C , Mitocôndrias/metabolismo , Mitocôndrias/parasitologia , Miócitos Cardíacos/metabolismo , Miócitos Cardíacos/parasitologia , Oxirredução , Ratos , Superóxido Dismutase/genética , Superóxidos , Trypanosoma cruzi/patogenicidade
8.
Trends Cardiovasc Med ; 27(2): 81-91, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27622432

RESUMO

Chagas disease is caused by the trypanosomatid Trypanosoma cruzi, which chronically causes heart problems in up to 30% of infected patients. Chagas disease was initially restricted to Latin America. However, due to migratory events, this disease may become a serious worldwide health problem. During Chagas disease, many patients die of cardiac arrhythmia despite the apparent benefits of anti-arrhythmic therapy (e.g., amiodarone). Here, we assimilate the cardiac form of Chagas disease to an inflammatory cardiac disease. Evidence from the literature, mostly provided using experimental models, supports this view and argues in favor of new strategies for treating cardiac arrhythmias in Chagas disease by modulating cytokine production and/or action. But the complex nature of myocardial inflammation underlies the need to better understand the molecular mechanisms of the inflammatory response during Chagas disease. Here, particular attention has been paid to tumor necrosis factor alpha (TNF) and transforming growth factor beta (TGF-ß) although other cytokines may be involved in the chagasic cardiomyopathy.


Assuntos
Cardiomiopatia Chagásica/metabolismo , Sistema de Condução Cardíaco/metabolismo , Mediadores da Inflamação/metabolismo , Miocardite/metabolismo , Miócitos Cardíacos/metabolismo , Fator de Crescimento Transformador beta/metabolismo , Trypanosoma cruzi/patogenicidade , Fator de Necrose Tumoral alfa/metabolismo , Potenciais de Ação , Animais , Anti-Inflamatórios/uso terapêutico , Remodelamento Atrial , Cardiomiopatia Chagásica/tratamento farmacológico , Cardiomiopatia Chagásica/parasitologia , Cardiomiopatia Chagásica/fisiopatologia , Sistema de Condução Cardíaco/efeitos dos fármacos , Sistema de Condução Cardíaco/parasitologia , Sistema de Condução Cardíaco/fisiopatologia , Frequência Cardíaca , Interações Hospedeiro-Patógeno , Humanos , Mediadores da Inflamação/antagonistas & inibidores , Contração Miocárdica , Miocardite/tratamento farmacológico , Miocardite/parasitologia , Miocardite/fisiopatologia , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/parasitologia , Transdução de Sinais , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Remodelação Ventricular
9.
Exp Parasitol ; 166: 68-74, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27004468

RESUMO

Toxoplasma gondii pathogen is a threat to human health that results in economic burden. Unfortunately, there are very few high-efficiency and low-toxicity drugs for toxoplasmosis in the clinic. (+)-Usnic acid derived from lichen species has been reported to have anti-inflammatory, antibacterial, anti-parasitology, and even anti-cancer activities. Herein, the systematic effect of (+)-usnic acid and (+)-usnic acid-liposome on toxoplasma were studied in vitro and in vivo. The viability of toxoplasma tachyzoite was assayed with trypan blue and Giemsa staining; while the invasive capability of tachyzoite to cardiofibroblasts was detected using Giemsa staining. The survival time of mice and the changes in tachyzoite ultrastructure were studied in vivo. The results showed that (+)-usnic acid inhibited the viability of tachyzoite; pretreatment with (+)-usnic acid significantly decreased the invasion of tachyzoite to cardiofibroblasts in vitro; (+)-usnic acid and (+)-usnic acid-liposome extensively prolonged the survival time of mice about 90.9% and 117%, respectively; and improved the ultrastructural changes of tachyzoite, especially in dense granules, rhoptries, endoplasmic reticulum, mitochondria and other membrane organelles. In summary, these results demonstrate that (+)-usnic acid and (+)-usnic acid-liposome with low toxicity have an inhibitory effect on the viability of toxoplasma tachyzoite, and mainly destructed membrane organelles which are connected with the virulence of toxoplasma. These findings provide the basis for further study and development of usnic acid as a potential agent for treating toxoplasmosis.


Assuntos
Antiprotozoários/farmacologia , Benzofuranos/farmacologia , Toxoplasma/efeitos dos fármacos , Animais , Antiprotozoários/administração & dosagem , Benzofuranos/administração & dosagem , Células Cultivadas , Feminino , Fibroblastos/efeitos dos fármacos , Fibroblastos/parasitologia , Lipossomos , Masculino , Camundongos , Microscopia Eletrônica de Transmissão , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/parasitologia , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Toxoplasma/ultraestrutura , Toxoplasmose Animal/tratamento farmacológico , Usnea/química
10.
Parasitol Res ; 115(2): 779-85, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26526953

RESUMO

The inflammatory response in the myocardium is an important aspect of the pathogenesis of Chagas' heart disease raised by Trypanosoma cruzi. CD40, a transmembrane type I receptor belonging to the tumor necrosis factor receptor (TNFR) family, is expressed in a broad spectrum of cell types and is crucial in several inflammatory and autoimmune diseases. Activation of CD40 through ligation to CD40L (CD154) induces multiple effects, including the secretion of proinflammatory molecules. In the present study, we examined the ability of T. cruzi to trigger the expression of CD40 in cardiac myocytes in vitro and in a murine model of chagasic cardiomyopathy. Our results indicate, for the first time, that T. cruzi is able to induce the expression of CD40 in HL-1 murine cardiomyocytes. Moreover, ligation of CD40 receptor upregulated interleukin-6 (IL-6), associated with inflammation. Furthermore, the induction of this costimulatory molecule was demonstrated in vivo in myocardium of mice infected with T. cruzi. This suggests that CD40-bearing cardiac muscle cells could interact with CD40L-expressing lymphocytes infiltrating the heart, thus contributing to inflammatory injury in chagasic cardiomyopathy.


Assuntos
Antígenos CD40/metabolismo , Cardiomiopatia Chagásica/parasitologia , Interleucina-6/metabolismo , Miócitos Cardíacos/imunologia , Trypanosoma cruzi/fisiologia , Animais , Antígenos CD40/genética , Células Cultivadas , Cardiomiopatia Chagásica/patologia , Modelos Animais de Doenças , Feminino , Regulação da Expressão Gênica , Interferon gama/farmacologia , Camundongos , Camundongos Endogâmicos C3H , Miocárdio/patologia , Miócitos Cardíacos/parasitologia , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Trypanosoma cruzi/imunologia
11.
Mem Inst Oswaldo Cruz ; 110(8): 996-1002, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26692329

RESUMO

Chagas disease, which is caused by the intracellular protozoan Trypanosoma cruzi, is a serious health problem in Latin America. The heart is one of the major organs affected by this parasitic infection. The pathogenesis of tissue remodelling, particularly regarding cardiomyocyte behaviour after parasite infection, and the molecular mechanisms that occur immediately following parasite entry into host cells are not yet completely understood. Previous studies have reported that the establishment of parasitism is connected to the activation of the phosphatidylinositol-3 kinase (PI3K), which controls important steps in cellular metabolism by regulating the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate. Particularly, the tumour suppressor PTEN is a negative regulator of PI3K signalling. However, mechanistic details of the modulatory activity of PTEN on Chagas disease have not been elucidated. To address this question, H9c2 cells were infected with T. cruzi Berenice 62 strain and the expression of a specific set of microRNAs (miRNAs) were investigated. Our cellular model demonstrated that miRNA-190b is correlated to the decrease of cellular viability rates by negatively modulating PTEN protein expression in T. cruzi-infected cells.


Assuntos
Regulação para Baixo , MicroRNAs/fisiologia , Miócitos Cardíacos/parasitologia , PTEN Fosfo-Hidrolase/metabolismo , Biossíntese de Proteínas , Trypanosoma cruzi/metabolismo , Animais , Western Blotting , Linhagem Celular , Sobrevivência Celular , Formazans , Genes Reporter , Miócitos Cardíacos/metabolismo , PTEN Fosfo-Hidrolase/genética , Fosforilação , RNA Mensageiro/metabolismo , Ratos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sais de Tetrazólio , Trypanosoma cruzi/classificação
12.
Mem. Inst. Oswaldo Cruz ; 110(8): 996-1002, Dec. 2015. graf
Artigo em Inglês | LILACS | ID: lil-769833

RESUMO

Chagas disease, which is caused by the intracellular protozoanTrypanosoma cruzi, is a serious health problem in Latin America. The heart is one of the major organs affected by this parasitic infection. The pathogenesis of tissue remodelling, particularly regarding cardiomyocyte behaviour after parasite infection, and the molecular mechanisms that occur immediately following parasite entry into host cells are not yet completely understood. Previous studies have reported that the establishment of parasitism is connected to the activation of the phosphatidylinositol-3 kinase (PI3K), which controls important steps in cellular metabolism by regulating the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate. Particularly, the tumour suppressor PTEN is a negative regulator of PI3K signalling. However, mechanistic details of the modulatory activity of PTEN on Chagas disease have not been elucidated. To address this question, H9c2 cells were infected with T. cruzi Berenice 62 strain and the expression of a specific set of microRNAs (miRNAs) were investigated. Our cellular model demonstrated that miRNA-190b is correlated to the decrease of cellular viability rates by negatively modulating PTEN protein expression in T. cruzi-infected cells.


Assuntos
Animais , Ratos , Regulação para Baixo , MicroRNAs/fisiologia , Miócitos Cardíacos/parasitologia , Biossíntese de Proteínas , PTEN Fosfo-Hidrolase/metabolismo , Trypanosoma cruzi/metabolismo , Western Blotting , Linhagem Celular , Sobrevivência Celular , Formazans , Genes Reporter , Miócitos Cardíacos/metabolismo , Fosforilação , PTEN Fosfo-Hidrolase/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , RNA Mensageiro/metabolismo , Sais de Tetrazólio , Trypanosoma cruzi/classificação
13.
Microbes Infect ; 16(9): 768-77, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25102151

RESUMO

Previous studies have demonstrated loss/reduction of dystrophin in cardiomyocytes in both acute and chronic stages of experimental Trypanosoma cruzi (T. cruzi) infection in mice. The mechanisms responsible for dystrophin disruption in the hearts of mice acutely infected with T. cruzi are not completely understood. The present in vivo and in vitro studies were undertaken to evaluate the role of inflammation in dystrophin disruption and its correlation with the high mortality rate during acute infection. C57BL/6 mice were infected with T. cruzi and killed 14, 20 and 26 days post infection (dpi). The intensity of inflammation, cardiac expression of dystrophin, calpain-1, NF-κB, TNF-α, and sarcolemmal permeability were evaluated. Cultured neonatal murine cardiomyocytes were incubated with serum, collected at the peak of cytokine production and free of parasites, from T. cruzi-infected mice and dystrophin, calpain-1, and NF-κB expression analyzed. Dystrophin disruption occurs at the peak of mortality and inflammation and is associated with increased expression of calpain-1, TNF-α, NF-κB, and increased sarcolemmal permeability in the heart of T. cruzi-infected mice at 20 dpi confirmed by in vitro studies. The peak of mortality occurred only when significant loss of dystrophin in the hearts of infected animals occurred, highlighting the correlation between inflammation, dystrophin loss and mortality.


Assuntos
Doença de Chagas/metabolismo , Distrofina/fisiologia , Doença Aguda , Animais , Calpaína/metabolismo , Distrofina/metabolismo , Inflamação/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Miócitos Cardíacos/imunologia , Miócitos Cardíacos/parasitologia , NF-kappa B/metabolismo , Trypanosoma cruzi , Fator de Necrose Tumoral alfa/metabolismo
14.
Acta Trop ; 137: 161-73, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24879929

RESUMO

Sulfation, a post-translational modification which plays a key role in various biological processes, is inhibited by competition with chlorate. In Trypanosoma cruzi, the agent of Chagas' disease, sulfated structures have been described as part of glycolipids and we have reported sulfated high-mannose type oligosaccharides in the C-T domain of the cruzipain (Cz) glycoprotein. However, sulfation pathways have not been described yet in this parasite. Herein, we studied the effect of chlorate treatment on T. cruzi with the aim to gain some knowledge about sulfation metabolism and the role of sulfated molecules in this parasite. In chlorate-treated epimastigotes, immunoblotting with anti-sulfates enriched Cz IgGs (AS-enriched IgGs) showed Cz undersulfation. Accordingly, a Cz mobility shift toward higher isoelectric points was observed in 2D-PAGE probed with anti-Cz antibodies. Ultrastructural membrane abnormalities and a significant decrease of dark lipid reservosomes were shown by electron microscopy and a significant decrease in sulfatide levels was confirmed by TLC/UV-MALDI-TOF-MS analysis. Altogether, these results suggest T. cruzi sulfation occurs via PAPS. Sulfated epitopes in trypomastigote and amastigote forms were evidenced using AS-enriched IgGs by immunoblotting. Their presence on trypomastigotes surface was demonstrated by flow cytometry and IF with Cz/dCz specific antibodies. Interestingly, the percentage of infected cardiac HL-1 cells decreased 40% when using chlorate-treated trypomastigotes, suggesting sulfates are involved in the invasion process. The same effect was observed when cells were pre-incubated with dCz, dC-T or an anti-high mannose receptor (HMR) antibody, suggesting Cz sulfates and HMR are also involved in the infection process by T. cruzi.


Assuntos
Cloratos/metabolismo , Cisteína Endopeptidases/metabolismo , Endocitose/efeitos dos fármacos , Glicoconjugados/metabolismo , Redes e Vias Metabólicas/efeitos dos fármacos , Sulfatos/metabolismo , Trypanosoma cruzi/efeitos dos fármacos , Animais , Linhagem Celular , Eletroforese em Gel Bidimensional , Humanos , Immunoblotting , Ponto Isoelétrico , Microscopia Eletrônica , Miócitos Cardíacos/parasitologia , Processamento de Proteína Pós-Traducional , Proteínas de Protozoários , Coelhos , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Trypanosoma cruzi/metabolismo , Trypanosoma cruzi/fisiologia
15.
PLoS One ; 8(11): e79445, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24260222

RESUMO

Trypanosoma cruzi (T. cruzi) infection produces an intense inflammatory response which is critical for the control of the evolution of Chagas' disease. Interleukin (IL)-10 is one of the most important anti-inflammatory cytokines identified as modulator of the inflammatory reaction. This work shows that exogenous addition of IL-10 inhibited ERK1/2 and NF-κB activation and reduced inducible nitric oxide synthase (NOS2), metalloprotease (MMP) -9 and MMP-2 expression and activities, as well as tumour necrosis factor (TNF)-α and interleukin (IL)-6 expression, in T. cruzi-infected cardiomyocytes. We found that T. cruzi and IL-10 promote STAT3 phosphorylation and up-regulate the expression of suppressor of cytokine signalling (SOCS)-3 thereby preventing NF-κB nuclear translocation and ERK1/2 phosphorylation. Specific knockdown of SOCS-3 by small interfering RNA (siRNA) impeded the IL-10-mediated inhibition of NF-κB and ERK1/2 activation. As a result, the levels of studied pro-inflammatory mediators were restored in infected cardiomyocytes. Our study reports the first evidence that T. cruzi up- regulates SOCS-3 expression and highlights the relevance of IL-10 in the modulation of pro-inflammatory response of cardiomyocytes in Chagas' disease.


Assuntos
Interleucina-10/farmacologia , Miócitos Cardíacos/metabolismo , Miócitos Cardíacos/parasitologia , NF-kappa B/metabolismo , Proteínas Supressoras da Sinalização de Citocina/metabolismo , Trypanosoma cruzi/patogenicidade , Animais , Células Cultivadas , Masculino , Camundongos , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Miócitos Cardíacos/efeitos dos fármacos , Fosforilação/efeitos dos fármacos
16.
Autophagy ; 9(7): 1080-93, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23697944

RESUMO

Autophagy is a cell process that in normal conditions serves to recycle cytoplasmic components and aged or damaged organelles. The autophagic pathway has been implicated in many physiological and pathological situations, even during the course of infection by intracellular pathogens. Many compounds are currently used to positively or negatively modulate the autophagic response. Recently it was demonstrated that the polyamine spermidine is a physiological inducer of autophagy in eukaryotic cells. We have previously shown that the etiological agent of Chagas disease, the protozoan parasite Trypanosoma cruzi, interacts with autophagic compartments during host cell invasion and that preactivation of autophagy significantly increases host cell colonization by this parasite. In the present report we have analyzed the effect of polyamine depletion on the autophagic response of the host cell and on T. cruzi infectivity. Our data showed that depleting intracellular polyamines by inhibiting the biosynthetic enzyme ornithine decarboxylase with difluoromethylornithine (DFMO) suppressed the induction of autophagy in response to starvation or rapamycin treatment in two cell lines. This effect was associated with a decrease in the levels of LC3 and ATG5, two proteins required for autophagosome formation. As a consequence of inhibiting host cell autophagy, DFMO impaired T. cruzi colonization, indicating that polyamines and autophagy facilitate parasite infection. Thus, our results point to DFMO as a novel autophagy inhibitor. While other autophagy inhibitors such as wortmannin and 3-methyladenine are nonspecific and potentially toxic, DFMO is an FDA-approved drug that may have value in limiting autophagy and the spread of the infection in Chagas disease and possibly other pathological settings.


Assuntos
Autofagia/efeitos dos fármacos , Poliaminas/farmacologia , Trypanosoma cruzi/patogenicidade , Animais , Proteína 5 Relacionada à Autofagia , Células CHO , Cricetinae , Cricetulus , Eflornitina/farmacologia , Embrião de Mamíferos/citologia , Células Epiteliais/citologia , Células Epiteliais/efeitos dos fármacos , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/parasitologia , Camundongos , Camundongos Knockout , Proteínas Associadas aos Microtúbulos/deficiência , Proteínas Associadas aos Microtúbulos/metabolismo , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/metabolismo , Miócitos Cardíacos/parasitologia , Fagossomos/efeitos dos fármacos , Fagossomos/metabolismo , Espermidina/farmacologia , Fatores de Tempo , Trypanosoma cruzi/efeitos dos fármacos
17.
PLoS One ; 8(2): e57450, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23437390

RESUMO

RATIONALE: Cardiomyocytes express neurotrophin receptor TrkA that promotes survival following nerve growth factor (NGF) ligation. Whether TrkA also resides in cardiac fibroblasts (CFs) and underlies cardioprotection is unknown. OBJECTIVE: To test whether CFs express TrkA that conveys paracrine signals to neighbor cardiomyocytes using, as probe, the Chagas disease parasite Trypanosoma cruzi, which expresses a TrkA-binding neurotrophin mimetic, named PDNF. T. cruzi targets the heart, causing chronic debilitating cardiomyopathy in ∼30% patients. METHODS AND RESULTS: Basal levels of TrkA and TrkC in primary CFs are comparable to those in cardiomyocytes. However, in the myocardium, TrkA expression is significantly lower in fibroblasts than myocytes, and vice versa for TrkC. Yet T. cruzi recognition of TrkA on fibroblasts, preferentially over cardiomyocytes, triggers a sharp and sustained increase in NGF, including in the heart of infected mice or of mice administered PDNF intravenously, as early as 3-h post-administration. Further, NGF-containing T. cruzi- or PDNF-induced fibroblast-conditioned medium averts cardiomyocyte damage by H(2)O(2), in agreement with the previously recognized cardioprotective role of NGF. CONCLUSIONS: TrkA residing in CFs induces an exuberant NGF production in response to T. cruzi infection, enabling, in a paracrine fashion, myocytes to resist oxidative stress, a leading Chagas cardiomyopathy trigger. Thus, PDNF-TrkA interaction on CFs may be a mechanism orchestrated by T. cruzi to protect its heart habitat, in concert with the long-term (decades) asymptomatic heart parasitism that characterizes Chagas disease. Moreover, as a potent booster of cardioprotective NGF in vivo, PDNF may offer a novel therapeutic opportunity against cardiomyopathies.


Assuntos
Fibroblastos/efeitos dos fármacos , Glicoproteínas/farmacologia , Interações Hospedeiro-Parasita/genética , Miócitos Cardíacos/efeitos dos fármacos , Fator de Crescimento Neural/genética , Neuraminidase/farmacologia , Receptor trkA/genética , Trypanosoma cruzi/fisiologia , Animais , Cardiomiopatia Chagásica/etiologia , Cardiomiopatia Chagásica/genética , Cardiomiopatia Chagásica/metabolismo , Cardiomiopatia Chagásica/parasitologia , Doença de Chagas/complicações , Doença de Chagas/genética , Doença de Chagas/metabolismo , Doença de Chagas/parasitologia , Feminino , Fibroblastos/metabolismo , Fibroblastos/parasitologia , Regulação da Expressão Gênica/efeitos dos fármacos , Glicoproteínas/metabolismo , Humanos , Camundongos , Miócitos Cardíacos/metabolismo , Miócitos Cardíacos/parasitologia , Fator de Crescimento Neural/agonistas , Fator de Crescimento Neural/metabolismo , Neuraminidase/metabolismo , Especificidade de Órgãos , Cultura Primária de Células , Receptor trkA/metabolismo , Receptor trkC/genética , Receptor trkC/metabolismo , Transdução de Sinais/efeitos dos fármacos , Trypanosoma cruzi/patogenicidade
18.
Cell Microbiol ; 15(8): 1357-66, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23414299

RESUMO

Chronic Chagas cardiomyopathy (CCC), caused by the obligate intracellular protozoan parasite Trypanosoma cruzi, is a major cause of morbidity and mortality in Latin America. CCC begins when T. cruzi enters cardiac cells for intracellular multiplication and differentiation, a process that starts with recognition of host-cell entry receptors. However, the nature of these surface molecules and corresponding parasite counter-receptor(s) is poorly understood. Here we show that antibodies against neurotrophin (NT) receptor TrkC, but not against family members TrkA and TrkB, prevent T. cruzi from invading primary cultures of cardiomyocytes and cardiac fibroblasts. Invasion is also selectively blocked by the TrkC ligand NT-3, and by antagonists of Trk autophosphorylation and downstream signalling. Therefore, these results indicate that T. cruzi gets inside cardiomyocytes and cardiac fibroblasts by activating TrkC preferentially over TrkA. Accordingly, short hairpin RNA interference of TrkC (shTrkC), but not TrkA, selectively prevents T. cruzi from entering cardiac cells. Additionally, T. cruzi parasite-derived neurotrophic factor (PDNF)/trans-sialidase, a TrkC-binding protein, but not family member gp85, blocks entry dose-dependently, underscoring the specificity of PDNF as TrkC counter-receptor in cardiac cell invasion. In contrast to invasion, competitive and shRNA inhibition studies demonstrate that T. cruzi-PDNF recognition of TrkA, but not TrkC on primary cardiomyocytes and the cardiomyocyte cell line H9c2 protects the cells against oxidative stress. Thus, this study shows that T. cruzi via PDNF favours neurotrophin receptor TrkC for cardiac cell entry and TrkA for cardiomyocyte protection against oxidative stress, and suggests a new therapeutic opportunity in PDNF and/or fragments thereof for CCC therapy as entry inhibitors and/or cardioprotection agonists.


Assuntos
Fibroblastos/parasitologia , Miócitos Cardíacos/parasitologia , Estresse Oxidativo/fisiologia , Receptor trkA/fisiologia , Receptor trkC/fisiologia , Trypanosoma cruzi/patogenicidade , Animais , Células Cultivadas , Cardiomiopatia Chagásica , Modelos Animais de Doenças , Fibroblastos/patologia , Fibroblastos/fisiologia , Glicoproteínas/fisiologia , Interações Hospedeiro-Parasita/fisiologia , Camundongos , Camundongos Endogâmicos C57BL , Miócitos Cardíacos/patologia , Miócitos Cardíacos/fisiologia , Neuraminidase/fisiologia , RNA Interferente Pequeno/farmacologia , Receptor trkC/antagonistas & inibidores , Receptor trkC/efeitos dos fármacos , Trypanosoma cruzi/fisiologia
19.
Arq. bras. cardiol ; 98(3): 252-258, mar. 2012.
Artigo em Português | LILACS | ID: lil-622517

RESUMO

FUNDAMENTO: Métodos convencionais de dissector atualmente requerem consideráveis custos financeiros, técnicos e operacionais para estimar o número de células, incluindo cardiomiócitos, em uma área de 3D. OBJETIVO: Usar a microscopia de fluorescência em um método de dissector modificado para determinar o número de miócitos no tecido cardíaco em condições normais e patológicas. MÉTODOS: O estudo empregou camundongos Wistar machos com quatro meses de idade e peso de 366,25 ± 88,21 g randomizados em grupos controles (GC, n = 8) e infectados (GI, n = 8). Os animais do GI foram inoculados com cepa Y de T. cruzi (300.000 tripomastigotas/50 g). Após oito semanas, os animais foram pesados e sacrificados. Os Ventrículos Esquerdos (VE) foram removidos para análise estereológica da densidade numérica de cardiomiócitos (Nv [c]) e o número total dessas células no VE (N [c]). Esses parâmetros foram estimados usando um dissector fluorescente (DF) e comparados com os métodos convencionais de dissector óptico (DO) e dissector físico (DFi). RESULTADOS: Em ambos os métodos de dissector, os animais do GI apresentaram queda significativa de Nv[c] e N[c] em comparação com os animais do GC (P > 0,05). Uma correlação forte, igual ou superior a 96%, foi obtida entre DF, DO e DFi. CONCLUSÃO: O método DF parece ser igualmente confiável para determinar Nv[c] e N[c] em condições normais e patológicas, apresentando algumas vantagens em relação aos métodos convencionais de dissector: redução de cortes histológicos e imagens na análise estereológica, redução do tempo de análise das imagens, a construção de DF em microscópios simples, utilizando o modo de epifluorescência, distinção de planos de dissector em ampliações inferiores.


BACKGROUND: Conventional disector methods currently require considerable financial, technical and operational costs to estimate the number of cells, including cardyomyocytes, in a 3D area. OBJECTIVE: To use fluorescence microscopy in a modified disector method to determine the number of myocytes in cardiac tissue in normal and pathological conditions. METHODS: The study employed four-month-old male Wistar rats with weight of 366.25 ± 88.21g randomized in control (CG, n=8) and infected (IG, n=8) groups. IG animals were inoculated with T. cruzi Y strain (300,000 trypomastigotes/50g wt). After eight weeks, the animals were weighted and euthanized. The left ventricles (LV) were removed for stereological analysis of numerical density of cardiomyocytes (Nv[c]) and total number of these cells in the LV (N[c]). These parameters were estimated using a fluorescent disector (FD) and compared with the conventional optical (OD) and physical (PD) disector methods. RESULTS: In both disector methods, IG animals presented significant decrease of Nv[c] and N[c] compared to CG animals (P< 0.05). There was no significant difference in these variables despite the disector method applied in CG and IG animals (P> 0.05). A strong correlation, equal or above 96%, was obtained between FD, OD and PD. CONCLUSION: The FD method seems to be equally reliable to determine Nv[c] and N[c] in normal and pathological conditions and presents some advantages compared to conventional disector methods: reduction of histological slices and images in the stereological analysis, reduction of time to analyze the images, construction of FD in simple microscopes using the epifluorescence mode, distinction of disector planes in lower magnifications.


FUNDAMENTO: Métodos convencionales de disector actualmente requieren considerables costos financieros, técnicos y operativos para estimar el número de células, incluyendo cardiomiocitos, en un área de 3D. OBJETIVO: Usar la microscopia de fluorescencia en un método de disector modificado para determinar el número de miocitos en el tejido cardíaco en condiciones normales y patológicas. MÉTODOS: El estudio empleó ratones Wistar machos de cuatro meses de edad y peso de 366,25 ± 88,21 g randomizados en grupos controles (GC, n = 8) e infectados (GI, n = 8). Los animales del GI fueron inoculados con cepa Y de T. cruzi (300.000 tripomastigotas/50 g). Después de ocho semanas, los animales fueron pesados y sacrificados. Los Ventrículos Izquierdos (VI) fueron removidos para análisis estereológico de la densidad numérica de cardiomiocitos (Nv [c]) y el número total de esas células en el VI (N [c]). Esos parámetros fueron estimados usando un disector fluorescente (FD) y comparados con los métodos convencionales de disector óptico (OD) y disector físico (PD). RESULTADOS: En ambos métodos de disector, los animales del GI presentaron caída significativa de Nv[c] y N[c] en comparación con los animales del GC (P > 0,05). Una correlación fuerte, igual o superior a 96%, fue obtenida entre FD, OD y PD. CONCLUSIÓN: El método FD parece ser igualmente confiable para determinar Nv[c] y N[c] en condiciones normales y patológicas, presentando algunas ventajas en relación a los métodos convencionales de disector: reducción de cortes histológicos e imágenes en el análisis estereológico, reducción del tiempo de análisis de las imágenes, la construcción de FD en microscopios simples, utilizando el modo de epifluorescencia, distinción de planos de disector en ampliaciones inferiores.


Assuntos
Animais , Masculino , Ratos , Cardiomiopatia Chagásica/patologia , Ventrículos do Coração/patologia , Microscopia de Fluorescência/métodos , Miócitos Cardíacos/citologia , Contagem de Células/métodos , Cardiomiopatia Chagásica/parasitologia , Modelos Animais de Doenças , Ventrículos do Coração/parasitologia , Imageamento Tridimensional/métodos , Microscopia de Fluorescência/economia , Miócitos Cardíacos/parasitologia , Distribuição Aleatória , Ratos Wistar , Fatores de Tempo , Trypanosoma cruzi
20.
Int J Parasitol ; 41(5): 553-62, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21215746

RESUMO

Trypanosoma cruzi infection produces an intense inflammatory response in diverse tissues including the heart. The inflammatory reaction is critical for the control of the parasites' proliferation and evolution of Chagas disease. 15-Deoxy-Δ(12,14) prostaglandin J(2) (15dPGJ2) can repress the inflammatory response in many experimental models. However, the precise role of peroxisome proliferator-activated receptor γ (PPARγ) ligands in T. cruzi infection or in Chagas disease is poorly understood. This work reports the first evidence that 15dPGJ2 treatment increases the number of intracellular parasites as shown by fluorescence microscopy and it is also able to inhibit the expression and activity of different inflammatory enzymes such as inducible nitric oxide synthase (NOS-2), matrix metalloproteinases 2 and 9 (MMP-2, MMP-9), as well as pro-inflammatory cytokine (TNF-α and IL-6) mRNA expression in neonatal mouse cardiomyocytes after T. cruzi infection. Transfection of cardiomyocytes with small interfering RNA (siRNA) induces silencing of PPARγ and impairs the effects of 15dPGJ2 on the modulation of pro-inflammatory enzymes. Moreover, transfection restores the ability of these cells to control the intracellular growth of T. cruzi. We also found that PPARγ-independent pathways are involved, since 15dPGJ2 also exerts its effect through extracellular signal-regulated kinases-mitogen-activated protein kinase (Erk-MAPK) and nuclear factor-κB (NF-κB). The use of specific pharmacological inhibitors confirmed these findings. Our data point out that 15dPGJ2 is a potent modulator of the inflammatory process and regulator of parasites growth through PPARγ-dependent and independent (Erk-MAPK- and NF-κB) pathways in T. cruzi infected neonatal cardiac cells.


Assuntos
Antineoplásicos/uso terapêutico , Doença de Chagas/tratamento farmacológico , Doença de Chagas/imunologia , Miócitos Cardíacos/imunologia , Prostaglandina D2/análogos & derivados , Trypanosoma cruzi/fisiologia , Animais , Células Cultivadas , Doença de Chagas/genética , Doença de Chagas/parasitologia , Citocinas/genética , Citocinas/imunologia , Regulação para Baixo/efeitos dos fármacos , Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , Camundongos , Miócitos Cardíacos/parasitologia , PPAR gama/genética , PPAR gama/imunologia , Prostaglandina D2/uso terapêutico , Trypanosoma cruzi/efeitos dos fármacos , Trypanosoma cruzi/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA